These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23528279)

  • 21. Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.
    Longest W; Farkas D; Bass K; Hindle M
    Pharm Res; 2019 May; 36(8):110. PubMed ID: 31139939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental and numerical study of the dispersion of carbon dioxide plume.
    Xing J; Liu Z; Huang P; Feng C; Zhou Y; Zhang D; Wang F
    J Hazard Mater; 2013 Jul; 256-257():40-8. PubMed ID: 23669789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validating CFD predictions of respiratory aerosol deposition: effects of upstream transition and turbulence.
    Worth Longest P; Vinchurkar S
    J Biomech; 2007; 40(2):305-16. PubMed ID: 16533511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an effective two-equation turbulence modeling approach for simulating aerosol deposition across a range of turbulence levels.
    Jubaer H; Thomas M; Farkas D; Kolanjiyil AV; Momin MAM; Hindle M; Longest W
    J Aerosol Sci; 2024 Jan; 175():106262. PubMed ID: 38164243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Woolhouse R; Wynn E
    J Pharm Pharmacol; 2012 Sep; 64(9):1316-25. PubMed ID: 22881443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical aerosols deposition patterns from a Dry Powder Inhaler: Euler Lagrangian prediction and validation.
    Ravi Kannan R; Przekwas AJ; Singh N; Delvadia R; Tian G; Walenga R
    Med Eng Phys; 2017 Apr; 42():35-47. PubMed ID: 27993478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilaboratory particle image velocimetry analysis of the FDA benchmark nozzle model to support validation of computational fluid dynamics simulations.
    Hariharan P; Giarra M; Reddy V; Day SW; Manning KB; Deutsch S; Stewart SF; Myers MR; Berman MR; Burgreen GW; Paterson EG; Malinauskas RA
    J Biomech Eng; 2011 Apr; 133(4):041002. PubMed ID: 21428676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particle deposition in obstructed airways.
    Luo HY; Liu Y; Yang XL
    J Biomech; 2007; 40(14):3096-104. PubMed ID: 17499753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of LES of steady transitional flow in an idealized stenosed axisymmetric artery model with a RANS transitional model.
    Tan FP; Wood NB; Tabor G; Xu XY
    J Biomech Eng; 2011 May; 133(5):051001. PubMed ID: 21599092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational fluid dynamics analysis of cyclist aerodynamics: performance of different turbulence-modelling and boundary-layer modelling approaches.
    Defraeye T; Blocken B; Koninckx E; Hespel P; Carmeliet J
    J Biomech; 2010 Aug; 43(12):2281-7. PubMed ID: 20488446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CFD model for a 3-D inhaling mannequin: verification and validation.
    Anthony TR; Flynn MR
    Ann Occup Hyg; 2006 Mar; 50(2):157-73. PubMed ID: 16157607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Numerical simulations of particle behaviour in a realistic human airway model with varying inhalation patterns.
    Kadota K; Inoue N; Matsunaga Y; Takemiya T; Kubo K; Imano H; Uchiyama H; Tozuka Y
    J Pharm Pharmacol; 2020 Jan; 72(1):17-28. PubMed ID: 31713883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A CFD study of the effect of cyclone size on its performance parameters.
    Azadi M; Azadi M; Mohebbi A
    J Hazard Mater; 2010 Oct; 182(1-3):835-41. PubMed ID: 20656404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-aided design of dry powder inhalers using computational fluid dynamics to assess performance.
    Suwandecha T; Wongpoowarak W; Srichana T
    Pharm Dev Technol; 2016; 21(1):54-60. PubMed ID: 25265389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the motion of hard-shell capsules in dry powder inhalers.
    Benque B; Khinast JG
    Int J Pharm; 2019 Aug; 567():118481. PubMed ID: 31260784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutual enhancements of CFD modeling and experimental data: a case study of 1-mum particle deposition in a branching airway model.
    Longest PW; Oldham MJ
    Inhal Toxicol; 2006 Sep; 18(10):761-71. PubMed ID: 16774865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational fluid dynamics simulations of inhaled nano- and microparticle deposition in the rhesus monkey nasal passages.
    Schroeter JD; Asgharian B; Price OT; McClellan GE
    Inhal Toxicol; 2013 Oct; 25(12):691-701. PubMed ID: 24102469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of turbulence modelling on the assessment of platelet activation.
    Bozzi S; Dominissini D; Redaelli A; Passoni G
    J Biomech; 2021 Nov; 128():110704. PubMed ID: 34482226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Numerical Study on Particle Adhesion in Dry Powder Inhaler Device.
    Mitani R; Ohsaki S; Nakamura H; Watano S
    Chem Pharm Bull (Tokyo); 2020; 68(8):726-736. PubMed ID: 32741913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.